I ran across finesand's site when I was doing my DD in March. I didn't give it any weight either way because I'm finely tuned to double talk by BSers.

I came into CYDY just based on the HIV indication. mTNBC was interesting, but I hadn't yet educated myself on the possible mechanism of action of leronlimab on cancer. I wasn't sure whether leronlimab would react the same as maraviroc.

After many, many hours of research I became convinced of the efficacy and know this stock will far exceed my initial expectations.